Kerry J Savage

Results of a pivotal phase II study of brentuximab vedotin for patients with relapsed or refractory Hodgkin's lymphoma.

Scott E Smith, Bruce D Cheson, Andreas Engert, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The biology and management of systemic anaplastic large cell lymphoma.

K. Savage, Kerry J Savage, Greg Hapgood, 2015, Blood.

Population-based analysis of incidence and outcome of transformed non-Hodgkin's lymphoma.

Randy D Gascoyne, Laurie H Sehn, R. Gascoyne, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Molecular Signatures of Lymphoma

Randy D Gascoyne, R. Gascoyne, K. Savage, 2004, International journal of hematology.

ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project.

Stefano A Pileri, Lisa Rimsza, Randy D Gascoyne, 2008, Blood.

Frequent occurrence of deletions in primary mediastinal B‐cell lymphoma

Jan Delabie, Randy D Gascoyne, Andreas Rosenwald, 2007, Genes, chromosomes & cancer.